Skip to content
★ Sign in to follow
SE

Sean E. Harper

Executive
Total declarations
69
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€14.5M

Latest filing published 16 Jul 2018 for AMGEN INC, €255k.

Filing timeline

BuySale
Sean E. Harper

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

Sean E. Harper: trading record in brief

Sean E. Harper discloses dealings in Amgen Inc to SEC (Form 4). Between 14 March 2012 and 16 July 2018, the trades on record add up to 69 filings.

No open-market purchase appears, only 15 sales worth €14.5M. Other entries cover 47 share grants and 7 option exercises. Since January 2018: no purchases and 7 sales on the market.

The record was last updated on 16 July 2018 with an open-market sale (€255k) in Amgen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Sean E. Harper

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations65 total
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    298,458 USD12SEC
    1,525 shares@ US$195.717.0% of flowCommon StockSEC:0001127602-18-023315:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    281,012 USD11SEC
    1,525 shares@ US$184.274.1% of flowCommon StockSEC:0001127602-18-020733:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    265,503 USD11SEC
    1,525 shares@ US$174.101.8% of flowCommon StockSEC:0001127602-18-017561:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    124,700 USD11SEC
    736 shares@ US$169.430.8% of flowCommon StockSEC:0001127602-18-016535:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    0SEC
    4,508 shares0Common StockSEC:0001127602-18-015838:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    263,337 USD11SEC
    1,525 shares@ US$172.681.7% of flowCommon StockSEC:0001127602-18-014688:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    1M USD12SEC
    7,549 shares@ US$176.088.8% of flowCommon StockSEC:0001127602-18-012857:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    289,369 USD11SEC
    1,525 shares@ US$189.751.9% of flowCommon StockSEC:0001127602-18-012188:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    0SEC
    15,118 shares0Common StockSEC:0001127602-18-011020:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    265,625 USD11SEC
    1,525 shares@ US$174.181.7% of flowCommon StockSEC:0001127602-18-006488:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    89,694 USD11SEC
    453 shares@ US$198.000.6% of flowCommon StockSEC:0001127602-18-003451:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    115,910 USD11SEC
    606 shares@ US$191.270.8% of flowCommon StockSEC:0001127602-18-003451:1
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    283,071 USD11SEC
    1,525 shares@ US$185.621.9% of flowCommon StockSEC:0001127602-18-001997:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    269,666 USD11SEC
    1,525 shares@ US$176.831.9% of flowCommon StockSEC:0001127602-17-034510:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    261,660 USD23SEC
    1,525 shares@ US$171.581.8% of flowCommon StockSEC:0001127602-17-032117:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    283,574 USD11SEC
    1,525 shares@ US$185.952.0% of flowCommon StockSEC:0001127602-17-029692:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    0SEC
    4,551 shares0Common StockSEC:0001127602-17-016751:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    2M USD13SEC
    12,128 shares@ US$166.0415.2% of flowCommon StockSEC:0001127602-17-013093:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    0SEC
    23,092 shares0Common StockSEC:0001127602-17-011083:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    103,159 USD11SEC
    668 shares@ US$154.430.8% of flowCommon StockSEC:0001127602-17-003738:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    165,961 USD11SEC
    1,056 shares@ US$157.161.3% of flowCommon StockSEC:0001127602-17-003200:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    80,623 USD11SEC
    513 shares@ US$157.160.6% of flowCommon StockSEC:0001127602-17-003200:1
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    0SEC
    4,477 shares0Common StockSEC:0001127602-16-051290:0
  • ▼
    EVP, Research & DevelopmentExecutivesAmgen Inc
    3M USD25SEC
    21,875 shares@ US$157.9924.7% of flowCommon StockSEC:0000899243-16-019140:0
  • ◆
    EVP, Research & DevelopmentExecutivesAmgen Inc
    270,168 USD11SEC
    1,659 shares@ US$162.851.9% of flowCommon StockSEC:0001127602-16-050336:0

25 of 65 declarations